相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
Lan Wu et al.
NATURE CANCER (2020)
Nanolipid Formulations of Benzoporphyrin Derivative: Exploring the Dependence of Nanoconstruct Photophysics and Photochemistry on Their Therapeutic Index in Ovarian Cancer Cells
Girgis Obaid et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2019)
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Peng Guo et al.
SCIENCE ADVANCES (2019)
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
Jesus Garcia-Foncillas et al.
FRONTIERS IN ONCOLOGY (2019)
Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?
Girgis Obaid et al.
NANO LETTERS (2019)
Dual-receptor targeted strategy in nanoparticle design achieves tumor cell selectivity through cooperativity
Jared Francis Stefanick et al.
NANOSCALE (2019)
Photoimmunoconjugates: novel synthetic strategies to target and treat cancer by photodynamic therapy
Sara R. G. Fernandes et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
A photosensitive liposome with NIR light triggered doxorubicin release as a combined photodynamic-chemo therapy system
Qingpo Li et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent
Imran Rizvi et al.
LASERS IN SURGERY AND MEDICINE (2018)
Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer
Tanaya Vaidya et al.
PHARMACEUTICAL RESEARCH (2018)
RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.
Ann M. Gillenwater et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
Karie Runcie et al.
MOLECULAR MEDICINE (2018)
The significance of intertumor and intratumor heterogeneity in liver cancer
Jinping Liu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism
Zuzana Rychtarcikova et al.
ONCOTARGET (2017)
Iron addiction: a novel therapeutic target in ovarian cancer
D. Basuli et al.
ONCOGENE (2017)
Breaking Down the Barriers to Precision Cancer Nanomedicine
Christina von Roemeling et al.
TRENDS IN BIOTECHNOLOGY (2017)
Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids
Anne-Laure Bulin et al.
SCIENTIFIC REPORTS (2017)
Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation
Seung Min Jeong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Trastuzumab in the Treatment of Breast Cancer
Sofia Maximiano et al.
BIODRUGS (2016)
EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1
Biao Wang et al.
CANCER LETTERS (2016)
Transferrin receptor 1: a target for antibody-mediated cancer therapy
Tracy R. Daniels-Wells et al.
IMMUNOTHERAPY (2016)
Photonanomedicine: a convergence of photodynamic therapy and nanotechnology
Girgis Obaid et al.
NANOSCALE (2016)
Addressing intra-tumoral heterogeneity and therapy resistance
Brad Rybinski et al.
ONCOTARGET (2016)
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
Paolo Bossi et al.
ONCOTARGET (2016)
Nanoparticles in Photodynamic Therapy
Sasidharan Swarnalatha Lucky et al.
CHEMICAL REVIEWS (2015)
Intratumoral Heterogeneity: From Diversity Comes Resistance
Ariel Pribluda et al.
CLINICAL CANCER RESEARCH (2015)
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Nick Thatcher et al.
LANCET ONCOLOGY (2015)
Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas
Suraj Dixit et al.
MOLECULAR PHARMACEUTICS (2015)
Toward understanding and exploiting tumor heterogeneity
Ash A. Alizadeh et al.
NATURE MEDICINE (2015)
HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma
Netanya I. Pollock et al.
CLINICAL CANCER RESEARCH (2015)
HER2 aberrations in cancer: Implications for therapy
Min Yan et al.
CANCER TREATMENT REVIEWS (2014)
EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies
Reza Nedaeinia et al.
CURRENT DRUG TARGETS (2014)
Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment
Gerald S. Falchook et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
Henning Hanken et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2014)
Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma
Ning Jiang et al.
MOLECULAR CANCER THERAPEUTICS (2014)
HER3, serious partner in crime Therapeutic approaches and potential biomarkers for effect of HER3-targeting
Arjan Kol et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates
Bryan Q. Spring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecularly targeted cancer therapy: some lessons from the past decade
Min Huang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes
Jian-Qing Gao et al.
BIOMATERIALS (2013)
Detection of Novel Actionable Genetic Changes in Salivary Duct Carcinoma Helps Direct Patient Treatment
Valentina Nardi et al.
CLINICAL CANCER RESEARCH (2013)
Transferrin conjugation does not increase the efficiency of liposomal Foscan during in vitro photodynamic therapy of oesophageal cancer
Edyta Paszko et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Non-Invasive In Vivo Imaging of Near Infrared-labeled Transferrin in Breast Cancer Cells and Tumors Using Fluorescence Lifetime FRET
Ken Abe et al.
PLOS ONE (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Tracy R. Daniels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells
Adnan O. Abu-Yousif et al.
CANCER LETTERS (2012)
Targeting EGFR in Pancreatic Cancer Treatment
T. Troiani et al.
CURRENT DRUG TARGETS (2012)
Targeting the EGFR signaling pathway in cancer therapy
Parthasarathy Seshacharyulu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues
Alcides Chaux et al.
HUMAN PATHOLOGY (2012)
Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
Salvador J. Diaz-Cano
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition
Vladimir Tolmachev et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Dual targeting strategies with bispecific antibodies
Roland E. Kontermann
MABS (2012)
Evaluation of Diethyl-3-3'-(9,10-anthracenediyl)bis Acrylate as a Probe for Singlet Oxygen Formation during Photodynamic Therapy
David Kessel et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2012)
Efficient Delivery of Gold Nanoparticles by Dual Receptor Targeting
Sanjib Bhattacharyya et al.
ADVANCED MATERIALS (2011)
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck
J. M. del Campo et al.
BRITISH JOURNAL OF CANCER (2011)
Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF
Hanna Bjorkelund et al.
PLOS ONE (2011)
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Jonathan P. Celli et al.
CHEMICAL REVIEWS (2010)
Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance
Michelle D. Williams et al.
CLINICAL CANCER RESEARCH (2010)
Inhibition of functional HER family members increases the sensitivity to docetaxel in human ovarian cancer cell lines
Marcel N. A. Bijman et al.
ANTI-CANCER DRUGS (2009)
Mechanisms of Gambogic Acid-Induced Apoptosis in Non-Small Cell Lung Cancer Cells in Relation to Transferrin Receptors
Xiaoli Zhu et al.
JOURNAL OF CHEMOTHERAPY (2009)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)
R. Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas
Christel Larbouret et al.
CLINICAL CANCER RESEARCH (2007)
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
Jan B. Vermorken et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers
Justin M. Saul et al.
JOURNAL OF CONTROLLED RELEASE (2006)
In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors
AO Eniola et al.
BIOMATERIALS (2005)
Assessment of HER-2 status in pancreatic adenocarcinoma - Correlation of immunohistochemistry, quantitative real-time RT-PCR, and FISH with aneuploidy and survival
AJ Saxby et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid
S Kasibhatla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates
MD Savellano et al.
CANCER RESEARCH (2005)
Mechanics of receptor-mediated endocytosis
HJ Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy
R Hudson et al.
BRITISH JOURNAL OF CANCER (2005)
The biology of epidermal growth factor receptor in lung cancer
GV Scagliotti et al.
CLINICAL CANCER RESEARCH (2004)
Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas
E Ryschich et al.
EUROPEAN JOURNAL OF CANCER (2004)
The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors
B Khademi et al.
CANCER LETTERS (2002)
Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells
T Szekeres et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library
T Heitner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates
KL Molpus et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
